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Salt homeostasis is essential to survival, but brain
mechanisms for salt-intake control have not been
fully elucidated. Here, we found that the sensitivity
of Nax channels to [Na
+]o is dose-dependently
enhanced by endothelin-3 (ET-3). Nax channels
began to open when [Na+]o exceeded 150 mM
without ET-3, but opened fully at a physiological
[Na+]o (135–145 mM) with 1 nM ET-3. Importantly,
ET-3 was expressed in the subfornical organ
(SFO) along with Nax, and the level was robustly
increased by dehydration. Pharmacological experi-
ments revealed that endothelin receptor B (ETBR)
signaling is involved in this modulation of Nax gating
through protein kinase C and ERK1/2 activa-
tion. ETBR agonists increased the firing rate of
GABAergic neurons via lactate in the SFO, and an
ETBR antagonist attenuated salt aversion during
dehydration. These results indicate that ET-3
expression in the SFO is tightly coupled with
body-fluid homeostasis through modulation of the
[Na+]o sensitivity of Nax.
INTRODUCTION
As the major electrolyte of the extracellular fluid, sodium (Na)
plays a fundamental role in maintaining the volume and compo-
sition of every fluid compartment in the body (Fitzsimons, 1998).
As such, the amount of Na in body fluids must be tightly regu-
lated to ensure optimal performance of numerous physiological
processes based on the ion concentration across cell
membranes, including neuronal excitability, substance trans-
port, glomerular filtration and renal excretion of aqueous waste,
and the control of extracellular volume and blood pressure
(Daniels and Fluharty, 2004). Thus, Na is a key component of
many mammalian physiological functions. Disorders of Na
homeostasis induce severe consequences, such as exagger-Cated vascular reactivity, hypertension, or circulatory collapse
(Lin et al., 2005).
Nax, structurally classified as a family of voltage-gated Na
channels (Goldin et al., 2000), is a Na+ concentration ([Na+])-
sensitive channel with an apparent threshold value of
150 mM for extracellular [Na+] ([Na+]o) in vitro (Hiyama et al.,
2002; Noda, 2006). Nax is predominantly expressed in glial cells
(ependymal cells and astrocytes) of the circumventricular organs
(CVOs) in the brain, including the subfornical organ (SFO) and
organum vasculosum of the lamina terminalis (Watanabe et al.,
2000, 2006). Nax-knockout (Nax-KO) mice do not stop ingesting
salt even when dehydrated (Watanabe et al., 2000). This behav-
ioral anomaly of Nax-KO mice is reversed by site-directed
expression of the Nax gene in the SFO (Hiyama et al., 2004).
Nax thus appears to be the brain’s [Na
+]o sensor involved in
body-fluid homeostasis (Noda, 2007).
We subsequently revealed that Nax in glial cells stably inter-
acts with Na+/K+-ATPase to assist its activation (Shimizu et al.,
2007). Because activation of Na+/K+-ATPase consumes ATP,
Na+ influx via Nax leads to an increase of glucose uptake and
the activation of anaerobic glucose metabolism of Nax-positive
glial cells (Shimizu et al., 2007). Consequently, the release of
lactate from the glial cells is enhanced, and this lactate functions
as a gliotransmitter to stimulate GABAergic neurons surrounded
by the glial cells in the SFO (Shimizu et al., 2007). The supply of
lactate from glial cells to neurons appears to be central to the
control of salt-intake behavior in dehydrated animals (Shimizu
et al., 2007).
As aforementioned, Nax showed a threshold value of
150 mM for [Na+]o in vitro. However, we should note here
that [Na+] in serum and cerebrospinal fluid (CSF) is strictly
controlled at 135–145 mM in mammals, including humans
(Peruzzo et al., 2010), suggesting that the brain sensor(s) can
detect an increase in [Na+] in this range to strictly maintain the
physiological level. We therefore presumed that the threshold
value of Nax for [Na
+]o must bemodulated in vivo by somemech-
anism. The SFO has been shown to harbor not only sensors for
ionic conditions in body fluids but also receptors for a variety
of regulatory peptides (Mendelsohn et al., 1984; Saavedra
et al., 1986; Barth et al., 2004). Recently, a transcriptome anal-
ysis using a microarray revealed that ETBR, a receptor forell Metabolism 17, 507–519, April 2, 2013 ª2013 Elsevier Inc. 507
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+]endothelins (ETs), is extremely highly expressed in the rat SFO
(Hindmarch et al., 2008). ETBR is predominantly expressed in
glial cells in the brain (Hori et al., 1992). Furthermore, ET peptides
and their receptors are intimately involved in the physiological
control of systemic blood pressure and Na homeostasis (Kohan
et al., 2011). It is thus tempting to speculate that ET is involved in
signaling mechanisms mediated by sensor molecules such as
Nax in the SFO.
ETs are 21-amino-acid peptides originally cloned from aortic
endothelial cells (Kedzierski and Yanagisawa, 2001). Three
structurally related peptides, ET-1, ET-2, and ET-3, have been
identified (Kedzierski and Yanagisawa, 2001). In mammals, ETs
generate their biological effects via the activation of two receptor
subtypes: ET receptor type A (ETAR) and ET receptor type B
(ETBR). The rank order of affinity of ETs for ETAR is ET-1 >
ET-2 >> ET-3 at subnanomolar to micromolar concentrations,
whereas ETBR binds to ETs with approximately equal affinity in
the subnanomolar range (Kedzierski and Yanagisawa, 2001;
Arai et al., 1990; Sakurai et al., 1990). Both ETAR and ETBR are
seven-transmembrane proteins coupled to G proteins, leading
to multiple second messenger systems (Sokolovsky, 1995).
In the present study, we found that ET-3 shifts the [Na+]o
dependency of Nax activation to the lower-concentration side
in a dose-dependent manner, and thereby gated Nax even
when [Na+]o was in the physiological range. ETBR signaling
promoted activation of Nax through protein kinase C (PKC) path-
ways leading to extracellular signal-regulated kinase 1/2
(ERK1/2) activation. Importantly, expression of ET-3 in the SFO
was time-dependently enhanced during dehydration. Moreover,
a specific blocker of ETBR BQ788 attenuated the salt-aversive
behavior in wild-type (WT) mice induced by dehydration. These
results strongly indicate that regulated expression of ET-3 in
the SFO is involved in the control of salt-intake behavior through
improvement of the [Na+]o sensitivity of Nax in vivo.
RESULTS
ETBR Is Expressed in Nax-Positive Glial Cells in the SFO
We first attempted to identify cells expressing ETAR and ETBR
messenger RNA (mRNA) in the SFO in hydrated mice using
in situ hybridization. ETBR but not ETAR mRNA expression was
detected in ependymal cells facing the dorsal third ventricle
and inside cells of the SFO (Figure 1A). Because the expression
pattern of ETBR mRNA was highly similar to that of Nax mRNA
(see Shimizu et al., 2007), we examined whether Nax-positive
glial cells express ETBR in the SFO. Double immunostaining of
the SFO (Figure 1B) and dissociated SFO cells (Figure 1C) veri-
fied the coexpression of Nax and ETBR at the cellular level.
ET-3 and Endothelin-Converting Enzymes Are
Expressed in the SFO
We then investigated the expression of mRNAs for ETs (ET-1,
ET-2, and ET-3) in the SFO by in situ hybridization under
hydrated conditions (Figure 1D). ET-3 but not ET-1 or ET-2
mRNA was detected in ependymal cells of the SFO facing the
dorsal third ventricle and in some cells inside the SFO. Endothe-
lin-converting enzymes (Ece1 and Ece2), proteases responsible
for the conversion of inactive ET precursors (big endothelin) to
bioactive mature forms (Kedzierski and Yanagisawa, 2001),508 Cell Metabolism 17, 507–519, April 2, 2013 ª2013 Elsevier Inc.were also expressed in the SFO in a similar fashion (Figure 1E).
Sense probes gave no signals in in situ hybridization (data not
shown).
ET-3 Opens Nax Channels at 145 mM [Na
+]o via ETBR
Because Nax and ETBR colocalized at the cellular level, we theo-
rized that the gating (or signaling) of Nax is directly (or indirectly)
modulated by ET signaling via ETBR. To test this possibility, we
examined the effect of ET-3 on Nax activation using cells disso-
ciated from the SFO by intracellular Na+ imaging. Surprisingly,
ET-3 (0.1–10 nM) dose-dependently induced Na+ influx in
a subset of the SFO cells from WT mice in a 145 mM [Na+] solu-
tion, and these responsive cells were all positive for Nax (Figures
1F–1H; WT; ET-3, 0.1, 0.3, 1, or 10; BQ788 ). In contrast, cells
from Nax-KO mice did not respond to ET-3 at all (Figures 1F–1H;
KO; ET-3, 10; BQ788 ). Expectedly, the responses by ET-3
observed in WT cells were completely blocked by an ETBR
antagonist, BQ788 (Figures 1F–1H; WT; ET-3, 10; BQ788 +). Of
note, angiotensin II (Ang II; 100 nM) did not induce Na+ influx in
the SFO cells under the same condition (Figures 1G and 1H;
WT; Ang II).
We confirmed these results electrophysiologically by the
perforated patch-clamp method using b-escin (Fan and Palade,
1998). Addition of ET-3 (1 nM) to the perfusate ([Na+]o = 140 mM)
resulted in a gradual increase of whole-cell Na+ currents in Nax-
positive cells, reaching a plateau in 15 min (Figure 2A, WT; n = 8).
The ET-dependent current reversed at a potential close to the
Na+ equilibrium potential (ENa) (Figure 2B; 80 mV, ENa =
81.0 mV for [Na+]o = 140 mM). The reversal potentials shifted in
the negative direction as [Na+]o was decreased, and they agreed
well with values predicted by the Nernst equation for Na+ perme-
ability (data not shown). Of note, the current was not observed at
all in SFO cells of Nax-KO mice (Figure 2A, KO; n = 8). Taken
together, these data indicate that the inward current induced
by ET-3 is Na+ current mediated by Nax channels.
The plateau amplitude of the current was dependent on the
concentration of ET-3 ([ET-3]) and reached a peak at 10 nM
when [Na+]o was 140 mM (Figures 2C and 2D; ET-3 concentra-
tion that elicits half-maximal response, C1/2, was 0.52 nM). The
current response by ET-3was completely blocked by preincuba-
tion with 100 nM BQ788 (data not shown). As was expected, the
maximal level of the current density induced by ET-3 (1.5 pA/pF
at 10 nM ET-3; Figure 2D) was equal to that induced by an
increase of [Na+]o (1.5 pA/pF at 170 mM [Na+]o; Figure 2D).
ET-3 Signaling Shifts the [Na+]o Sensitivity for Nax
Gating toward the Lower Side
When the ‘‘high Na+ solution’’ ([Na+]o = 170 mM) was applied to
the SFO cells derived from WT mice, inward currents (the
maximumcurrent)were observed inNax-positive cells (Figure 2E,
i). It was not inactivated under the high-Na+ solution conditions,
but it disappeared rapidly when [Na+]o was set back to the basal
level ([Na+]o = 140 mM). These current properties observed in
Nax-positive glial cells in the SFO are thus similar to those previ-
ously reported in Nax-positive DRG neurons, including noninac-
tivating currents with a linear I-V relationship (Hiyama et al.,
2002).
After the amplitude of ET-3-induced current almost reached
the maximum level (under the condition that Nax channels
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Figure 1. ET-3 Induces Na+ Influx in Nax-Positive Cells in the SFO via ETBR
(A) In situ hybridization for ETAR and ETBRmRNAs on coronal sections of the SFO. ETBR signals were detected in ependymal cells facing the D3V and astrocytes
inside the SFO. Scale bars, 100 mm. VHC, ventral hippocampal commissure; D3V, dorsal third ventricle.
(B) Double immunohistochemical detection of ETBR and Nax. Scale bar, 50 mm.
(C) Double immunocytochemical detection of ETBR and Nax in a dissociated SFO cells. Colocalization of ETBR and Nax was observed in the plasma membrane.
Nax-positive cells are large round cells, which we previously identified as glial cells (ependymal cells and astrocytes; Shimizu et al., 2007). Scale bar, 10 mm.
(D) In situ hybridization for ET-1, ET-2, and ET-3 mRNAs. Neither ET-1 nor ET-2 mRNA was detected. ET-3 mRNA was detected in ependymal cells and cells
inside the SFO. Scale bars, 100 mm.
(E) In situ hybridization of Ece1 and Ece2. Ece1 and Ece2 mRNA were detected in ependymal cells and cells inside the SFO. Scale bars, 100 mm.
(F) Representative images of Na+ influx in SFO cells obtained from WT and Nax-KO (KO) mice. The pseudocolor images indicate the intracellular Na
+ concen-
tration ([Na+]i) at 0 and 20min after the start of the application of 10 nMET-3. In the experiments on ETBR inhibition, BQ788 (100 nM) was added to the extracellular
solution 20 min before the start of the experiments. Large round glial cells showed the response. Scale bars, 30 mm.
(G) Time course of the cellular Na+ imaging. The ordinate indicates the fluorescence ratio (DF; 340/380 nm) representing [Na+]i. The fluorescence ratio at 0min was
set as zero points on the ordinate. The extracellular fluid ([Na+]o = 145 mM) was changed to that containing ET-3 or angiotensin II at 0 min. Data were collected
from large round cells, which were identified as Nax-positive glial cells by immunostaining. Data are mean ±SEM (n = 20 for each). BQ788 , vehicle; BQ788 +,
100 nM BQ788; Ang II, 100 nM angiotensin II.
(H) Summary of the rate of increase in [Na+]i (Slope) in (G). The ordinate indicates the slope of the change in the fluorescence ratio between 3 and 8min, where the
graph shows good linearity. **p < 0.01, two-tailed Student’s t test; data are mean ±SEM (n = 20 for each).
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+]were almost open by ET-3), the high-Na+ solution was applied
further to estimate the additional current amount produced
[Na+]o dependently (Figure 2E, ii). The additional currentCresponse was expectedly very small, and the total current ampli-
tude from the basal level (indicated with a dotted line in blue) was
almost the same as that at (i). This is consistent with the notionell Metabolism 17, 507–519, April 2, 2013 ª2013 Elsevier Inc. 509
Figure 2. ET-3 Signaling Shifts the [Na+]o
Dependency of Nax Activation to the Lower
Side
(A) Representative whole-cell current responses in
the large round glial cells obtained from the SFO of
WT and Nax-KO (KO) mice on application of 1 nM
ET-3. Current deflections represent current
responses to 1 s voltage ramps that were applied
every 1 min (from 90 to +90 mV). The holding
potential was set at 45 mV. The currents were
recorded with patch pipettes filled with a Cs+-
based pipette solution containing tetraethy-
lammonium to block K+ currents. The dotted lines
represent the basal level without ET-3 application.
(B) Representative ramp currents of the WT and
KO cells obtained 15 min after the start of the ET-3
application.
(C) Representative whole-cell current responses
in the WT and KO cells on application of 0.3, 1,
or 10 nM ET-3, under the 140 mM [Na+]o con-
dition. The dotted lines represent the basal level
without ET-3.
(D) Relationships between the current density
(current amplitude/cell capacitance) and [ET-3] in
the SFO cells obtained fromWT and KOmice. The
current amplitude from the basal level was
measured 20 min after the start of the ET-3
application. The abscissa is shown in the loga-
rithmic scale. [Na+]o at the half-maximal response
(C1/2) was determined by curve fitting; the curve is
shownwith a solid line. Data aremean ±SEM (n = 6
for each).
(E) A representative whole-cell current response of
a SFO cell obtained from WT mice on application
of hypertonic Na+. The transient application of
hypertonic Na+ (170 mM) was performed at the time points indicated by arrows, 5 min before (i) and 30 min after (ii) the start of the ET-3 application (1 nM). The
dotted lines represent the basal level under the 140 mM [Na+]o condition without ET-3. The currents induced by an increase in [Na
+]o (30 mM) at the time points (i)
and (ii) are magnified below.
(F) Relationships between the current density and [Na+]o in the presence or absence of 1 nMET-3. The current amplitudes from the basal level weremeasured and
plotted. For comparisons, the current changes due to the shift of the ENa were compensated. Data are mean ±SEM (n = 6 for each point). The C1/2 values were
determined after curves fitting (solid lines).
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+]that both [Na+]o- and [ET]-dependent currents are mediated by
Nax channels.
We further examined the relationship between [Na+]o- and
[ET]-dependent responses. The [Na+]o-dependent response
reached a maximum at 170 mM without ET-3; here, C1/2 was
161 mM (Figure 2F; [ET-3] = 0 nM). This C1/2 value matched
well with our previous estimation (157 mM) obtained using
Na+-imaging techniques (Hiyama et al., 2002). When 1 nM
ET-3 was applied, the response curve of [Na+]o dependency
shifted to the lower side; the C1/2 value was shifted to 133 mM
(Figure 2F; [ET-3] = 1 nM). Intriguingly, the slope of [Na+]o-depen-
dence curve at 1 nM ET-3 was less steep than that without ET-3,
indicating that ET-3 signaling makes Nax channels sensitive in
a wider range of [Na+]o (Figure 2F).
Modulation of Nax Gating by ET-3 in SFO Cells Was
Reproduced in C6 Cells Expressing both Nax and ETBR
We next tested by Na+ imaging whether the Nax response
observed in the SFO cells is reproducible in C6M16 cells (Shi-
mizu et al., 2007), in which the expression of Nax channels can
be induced by the Tet-off system (Figure 3A). We confirmed
beforehand that ETBR is expressed in C6M16 cells (Figures 3B510 Cell Metabolism 17, 507–519, April 2, 2013 ª2013 Elsevier Inc.and 3C). In the Nax-positive C6M16 cells, ET-3 (10 nM) at
145 mM [Na+]o induced Na
+ influx with a similar time course as
the SFO cells, and the response was blocked by the ETBR
antagonist BQ788 (Figure S1 available online). Consistently,
the ETBR-specific agonist IRL1620 induced Na
+ influx in
a dose-dependent manner with a saturated response at
100 nM (Figure 3D). Here, it should be noted that ETBR activation
did not affect the cell-surface expression of Nax in Nax-positive
C6M16 cells (Figure S2).
The relationship between [Na+]o- and [ET]-dependent activa-
tion of Nax was examined in depth using C6M16 cells by Na
+-
imaging experiments. Without the ETBR agonist IRL1620, the
[Na+]o-dependent response reached a maximum at 170 mM;
here, C1/2 was estimated as 161 mM (Figure 3E; IRL, 0; BQ ).
The [Na+]o-dependence curve did not significantly differ in the
presence and absence of the ETBR antagonist BQ788 (100 nM)
(Figure 3E; compare IRL, 0; BQ + with IRL, 0; BQ ). When
IRL1620 was applied at 50 nM, however, the [Na+]o dependency
of the response shifted to the lower side; C1/2 was shifted to
146 mM (Figure 3E; IRL, 50; BQ ). When IRL1620 was applied
at 100 nM, the [Na+]o-dependence curve further shifted toward
a lower [Na+]o; C1/2 was 132 mM (Figure 3E; IRL, 100; BQ ).
Figure 3. ETBR Agonist Induces Na
+ Influx in a Cell Line Expressing
Nax and ETBR
(A) Immunostaining for Nax expressed in C6M16 cells. The Tet-off regulator
induces the expression of Nax. Scale bars, 25 mm.
(B) ETBRmRNA expression in the C6M16 cells. Total RNA extracted from Nax-
negative [Tet-off ()] and Nax-positive [Tet-off (+)] C6M16 cells was subjected
to RT-PCR. Rplp0, ribosomal protein large P0 used as a control.
(C) Immunostaining of ETBR and Nax in C6M16 cells. Scale bar, 20 mm. DIC,
differential interference contrast image.
(D) Left: Intracellular Na+ imaging with the ETBR agonist IRL1620 at each dose
in Nax-positive C6M16 cells. Right: Summary of the fluorescence ratio (DF) at
20 min in the left panel. **p < 0.01, two-tailed Student’s t test; data are
mean ±SEM (n = 30 for each).
(E) Relationships between the rate of increase in [Na+]i (Slope) and [Na
+]o at
various concentrations of IRL1620 and ET-3 in the presence or absence of
BQ788 (100 nM). The ordinate indicates the slope in the curve of the fluores-
cence ratio between 5 and 10 min. The values of C1/2 were determined by
curve fitting (solid lines). Data are mean ±SEM (n = 30 for each). BQ, vehicle;
BQ +, 100 nM BQ788. See also Figures S1 and S2.
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CBQ788 (100 nM) completely abrogated the shift of the curves by
IRL1620 (Figure 3E; IRL, 50; BQ + and IRL, 100; BQ +). Because
IRL1620 at 100 nM induced full activation of Nax (see Figure 3D),
the response curve at 100 nM IRL1620 indicates that an [Na+]o of
at least 100 mM is required for the activation of Nax by ETBR
signaling (Figure 3E; IRL, 100; BQ ).
Of note, 50 pM ET-3 did not shift the curve at all (Figure 3E;
ET-3, 50; BQ ). This suggests that it is unlikely that ET-3 from
blood or CSF activates Nax in the SFO (see below), even though
the CVOs lack a blood-brain barrier.
Nax Activation Is Mediated by PKC Pathways Leading to
ERK1/2 Activation Downstream
The signaling from ETBR is reportedly transduced via Gai- and
Gaq-dependent pathways (Rauh et al., 2008). Gai directly acti-
vates Src, which leads to activation of Ras/Raf. Conversely,
the Gaq pathway first activates PKC and then activates Src and
Ras/Raf (Robin et al., 2002). Both pathways eventually converge
to activate ERK1/2 downstream through mitogen-activated
protein kinase/ERK kinase (MEK) (Figure 4A). We tested whether
this is also the case for C6M16 cells. After stimulation with the
ETBR agonist IRL1620, we first examined ERK1/2 activation
with an anti-phospho-ERK1/2 antibody using C6M16 cells ex-
pressing Nax. The phosphorylation of ERK1/2 was time-depen-
dently increased by IRL1620, peaking at 10 min (Figure 4B).
We then pharmacologically investigated which ETBR
signaling cascade is involved in the activation of Nax. The
ETBR agonist-induced Na
+ influx was not affected by a Gai
inhibitor, pertussis toxin (PTX) (Figure 4C), suggesting that the
pathway indicated by dotted lines in Figure 4A is not used in
C6M16 cells. On the other hand, the Na+ influx was reduced
to the basal level by the addition of inhibitors for PKC (bisindo-
lylmaleimide I), MEK (U0126), and ERK1/2 (FR180204), respec-
tively, but only partially blocked by an inhibitor of Src, 4-amino-
5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2)
(Figure 4C). These results indicate that the activation of Nax
channels by ETs occurs downstream of Gaq, but not Gai and
that ERK1/2 activation downstream of PKC is essential for
the Na+ influx (Figure 4A). Also, IRL1620-induced phosphoryla-
tion of ERK1/2 was not blocked by PTX, but was blocked by
inhibitors for PKC, Src, and MEK, respectively (Figure S3,
IRL1620).
ET-3 Stimulates Cellular Glucose Uptake
As the Na+ influx via Nax directly stimulates Na
+/K+-ATPase
activity to pump out intracellular Na+ ions and leads to enhance-
ment of cellular glucose uptake and glycolysis (Shimizu et al.,
2007), we assessed glucose uptake using a fluorescent glucose
derivative, 2-NBDG, using the native cells from the SFO (Figures
5A–5D). We found that there existed cellular populations that
intensively took up 2-NBDG on the application of ET-3 (10 nM)
among the WT mouse cells but not the Nax-KO cells (Figures
5A, 5B, and 5D). Importantly, these active cells were all positive
for Nax (Figure 5A), and the glucose-uptake activity was inhibited
by the Na+/K+-ATPase inhibitor ouabain (1 mM; Figures 5C and
5D). These results indicate that the activation of Nax channels by
ETBR signaling stimulates glucose metabolism in Nax-positive
glial cells in the SFO. We further confirmed that Nax-positive
C6M16 cells also show enhancement of glucose uptake by theell Metabolism 17, 507–519, April 2, 2013 ª2013 Elsevier Inc. 511
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Figure 4. ETBR Signaling Pathway Respon-
sible for Nax-Dependent Na
+ Influx
(A) Activation cascades of Nax via the ETBR
receptor based on our experimental results. The
kinase inhibitors used in the experiments are indi-
cated in red. The pathway indicated by dotted lines
was suggested not to work in the Nax activation by
ETBR signaling (see Figures 4C, S3, and S4).
(B) ERK1/2 phosphorylation induced by 100 nM
IRL1620. Extracts from Nax-positive C6M16 cells
were analyzed by western blotting using anti-
phospho-ERK1/2 and anti-ERK1/2.
(C) Left: The effects of kinase inhibitors on Na+-
influx induced by 100 nM IRL1620 in Nax-positive
C6M16 cells. Inhibitors used are as follows: for Gai
(T; 100 ng/ml pertussis toxin), PKC (B; 3.75 mM
bisindolylmaleimide I), Src (P; 10 mM PP2), MEK
(U; 20 mM U0126), or ERK (F; 10 mM FR180204).
The ordinate shows the fluorescence ratio (DF).
The fluorescence ratio at 0 min was set as zero.
Right: Summary of the fluorescence ratio at 20min
in the left panel. **p < 0.01, two-tailed Student’s
t test; data are mean ±SEM (n = 30 for each). See
also Figure S3.
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+]ETBR agonist, and this enhancement was blocked by inhibitors
for PKC, MEK, ERK, and Src, expectedly (Figure S4).
ET-3 Enhances Lactate Release in the SFO
Increased demand for glucose and stimulation of cellular anaer-
obic glycolysis by glial cells brings about the release of lactate
(Shimizu et al., 2007). This suggests that Nax activation by ET-3
also leads to the promotion of lactate release from Nax-positive
glial cells in the SFO. To confirm this view, we measured the
amounts of lactate released from the SFO (Figure 5E). After the
incubation of the SFO from WT mice with solutions containing
10 nM ET-3, the lactate concentration in the solutions was higher
by more than 50% compared with that without ET-3 (Figure 5E;
WT). This upregulation was completely abolished by 1 mM
ouabain. In contrast, solutions containing ET-3 incubated with
theSFO fromNax-KOmice showedno such increases (Figure 5E;
KO). These results indicate that anaerobic glycolysis was stimu-
lated in Nax-positive glial cells of the SFO by ETBR signaling.
ET-3 Activates GABAergic Neurons in the SFO Nax
Dependently
Activation of Nax in glial cells leads to an upregulation of the firing
activity of GABAergic neurons in the SFO through secretion of
lactate as a gliotransmitter (Shimizu et al., 2007). We next exam-
ined the effect of ET-3 on neuronal activities of GABAergic
neurons in the SFO. We prepared acute slices containing the
SFO from GAD-GFP and GAD-GFP/Nax-KO mice (see Wata-
nabe et al., 2006; GAD, glutamic acid decarboxylase), respec-512 Cell Metabolism 17, 507–519, April 2, 2013 ª2013 Elsevier Inc.tively, and examined the firing activity of
GABAergic neurons using patch-clamp
techniques in the cell-attached mode
(Figures 5F and 5G). The GABAergic
neurons carrying the fluorescence of
GFP as a marker in the SFO of both WT
and Nax-KO mice showed spontaneousfiring at a similar frequency under normal ([Na+]o = 145 mM)
conditions (4 Hz; see Figure 5F, ET-3, 0). Upon addition of
ET-3 (>0.3 nM) to the perfusate, the firing frequency in WT
mice gradually increased. The average frequency during the
15–20 min after the ET-3 application showed concentration-
dependent enhancement (Figure 5G; ET-3; 0.3, 1, 10), and
ET-3 at 10 nM doubled the frequency (8 Hz). This increase
was not observed in Nax-KO mice upon the addition of 10 nM
ET-3 (Figures 5F and 5G, KO).
Lactate is known to be taken in by monocarboxylate trans-
porters (MCTs) and fuel oxidative metabolism in neurons
(Gladden, 2004). Therefore, we examined the effects of
a-cyano-4-hydroxycinnamic acid (a-CHCA), an inhibitor of
MCTs, on the firing rate, as we previously reported (Shimizu
et al., 2007). The activation was abolished by preincubation not
only with the ETBR antagonist BQ788 but also with a-CHCA (Fig-
ure 5G), indicating that the activation of SFOGABAergic neurons
by ET-3 was mediated by lactate signaling. These results with
ET-3 were reproduced in experiments with the ETBR agonist
IRL1620 (Figure 5H). Upon addition of IRL1620 (100 nM) to the
perfusate, the firing frequency of GABAergic neurons from WT
mice, but not from Nax-KO mice, gradually doubled. The
enhancement of GABAergic activities was again abolished by
preincubation with BQ788 or a-CHCA.
ET-3 Expression Is Induced by Dehydration
Next, we examined the expression of ET-3 during dehydration
and found that the level of ET-3 mRNA in the SFO increased
A B E
C
D
F
G H
Figure 5. ETBR Activation Causes Enhancement of
Glucose Uptake and Lactate Release in Nax-Positive
Glial Cells and Leads to an Increase in the Firing
Activity of GABAergic Neurons in the SFO
(A–C) Glucose imaging of dissociated SFO cells from WT (A,
C) and Nax-KO (B) mice 20 min after the application of vehicle
or 1 nM ET-3 in a 140 mM Na+ solution. To inhibit the activity
of Na+/K+-ATPase, 1 mM ouabain was added to the extra-
cellular solution (C). After the imaging, cells were stained with
the anti-Nax channel antibody (Nax; red). Scale bars, 30 mm.
(D) Summary of glucose imaging of the SFO cells. Data were
obtained from Nax-positive cells. The mean fluorescence
intensity inWTmice given vehicle was set at 100%. **p < 0.01,
two-tailed Student’s t test; data are mean ±SEM (n = 20 for
each).
(E) Lactate release from the SFO tissue into the incubation
medium. SFO tissues from WT or Nax-KO (KO) mice were
incubated for 24 hr at 37C, and themediumwas subjected to
measurements. Ouabain was added at 1 mM. *p < 0.05, two-
tailed Student’s t test; data are mean ±SEM (n = 6 for each).
(F) Time course of the firing frequency in GABAergic neurons
in the SFO tissues from GAD-EGFP/Nax-WT (WT) mice. SFO
tissues were treated with ET-3 during the indicated period.
(G and H) Summary of the firing frequency of GABAergic
neurons in the SFO of GAD-EGFP/Nax-WT (WT) and GAD-
EGFP/Nax-KO (KO) mice treated with ET-3 (G) or 100 nM
IRL1620 (H). Average values of the firing frequency during 15–
20 min were calculated. BQ788 and a-CHCA (an inhibitor of
monocarboxylate transporters) was applied at 100 nM and
5mM, respectively. *p < 0.05, **p < 0.01, two-tailed Student’s
t test; data aremean±SEM (n =8 for each). See also Figure S4.
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+]time dependently (Figures 6A and 6B; approximately 10-fold at
36 hr as estimated from the signal intensity by in situ hybridiza-
tion). On the other hand, ETBR expression is not regulated byCell Metabolismdehydration (in situ hybridization; data not shown),
consistent with a previous finding obtained with
a microarray (Hindmarch et al., 2008). The
secreted ET-3 level in the SFO tissues was
estimated by 1 hr incubation with different solu-
tions (high Na+, high osmolality, or high K+) repre-
senting various conditions (Figure 6C). The ET-3
levels detected in the incubation solutions with
the SFO from 48 hr dehydrated animals were all
6- to 8-fold larger than those from hydrated
animals irrespective of the stimuli during the incu-
bation, suggesting that ET-3 had been already
secreted in the SFO tissues in vivo. As was ex-
pected, immunohistochemical analysis revealed
that the phosphorylation of ERK1/2 was markedly
enhanced in the SFO of dehydrated mice
(Figure 6D).
Intriguingly, the specific upregulation of ET-3
expression by dehydration was observed not
only inWTmice but also inNax-KOmice (Figure 6E,
WT and KO; estimated as 3.9 ± 0.7-fold by RT-
PCR; n = 3), indicating that Nax is not involved in
this regulation. In contrast, the expression of
ET-1 or ET-2 was not induced by dehydration (Fig-
ure 6E; see also Figure 1D). Of note, in vitro incuba-
tion of the SFO tissues from hydrated WT mice for24 hr in a high Na+ (170 mM [Na+]o) or hyperosmotic (350 mOsm;
adjusted with mannitol) solution did not enhance the expression
of ET-3 in the SFO (by in situ hybridization; data not shown),17, 507–519, April 2, 2013 ª2013 Elsevier Inc. 513
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Figure 6. ET-3 Expression Is Enhanced by Dehydration
(A) In situ hybridization for detection of ET-3 expression in the SFO of WTmice. Brains were obtained frommice provided freely with food and water (0 hr) or from
those provided only with food during the indicated period (12, 24, 36, and 48 hr). In this experiment, specimen sets covering all conditions (0, 12, 24, 36, or 48 hr)
were attached on the same glass slide for comparison. Sections on the same slide are shown.
(legend continued on next page)
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ET-3 Activates Nax Channels at Physiological [Na
+]suggesting that ET-3 expression is regulated by a signal from
outside the SFO.
No Relation Was Detected between ET-3 Expression in
the SFO and Ang II Expression
Ang II levels in blood and CSF increase under dehydrated condi-
tions. Animals treated with Ang II increase their consumption of
salt solutions in addition to water (Buggy and Fisher, 1974). We
therefore examined the possibility that ET-3 and Ang II interact
at some level. First, we investigated whether ET-3 or Nax
signaling regulates Ang II production. Ang II levels in blood and
SFO showed a 2-fold increase at 48 hr dehydration (Figure 6F):
The upregulation in the SFO is consistent with a previous report
using rats (Barth and Gerstberger, 1999). Importantly, the levels
did not differ between WT and Nax-KO mice under hydrated or
dehydrated conditions (Figure 6F), suggesting that Nax signals
are not involved in the regulation of Ang II production. Nax-KO
mice exhibit defects in salt-intake behavior, but not robust differ-
ences in water intake, blood pressure, or heart rate, under dehy-
drated conditions (data not shown). This also supports the view
that Nax signaling is not involved in the regulation of Ang II. In
addition, Ang II levels in blood and SFO were not affected by
the intracerebroventricular (i.c.v.) infusion of BQ788, which
inhibits ETBR (Figure 6F), indicating that ET-3 expression in the
SFO is not relevant to Ang II production. Thus, it is unlikely that
there is a direct relation between ETBR (or Nax) signaling and
Ang II levels.
Next, we tested whether the renin-angiotensin system (RAS) is
involved in the regulation of ET-3 expression. However, we could
not obtain any data showing that Ang II is involved in the regula-
tion of ET-3 in the SFO (Figure S5; see Supplemental Results).
ETBR Antagonist Attenuates Salt Aversion in
Dehydrated Mice through Modulation of the Gating
Mechanism of Nax
Finally, we verified the physiological significance of ETBR activa-
tion to salt-intake behavior. We examined salt appetite using
a two-bottle test in combination with the i.c.v. infusion of an
ETBR blocker, BQ788 (500 pmol/hr). Because the i.c.v. infusion
of ET-3 significantly reduced the fluid intake of animals via
unknown mechanisms (data not shown), we used a specific
antagonist of ETBR (BQ788) for this experiment. Continuous infu-
sion of BQ788 or vehicle was performed for 2 days under
hydrated and dehydrated conditions, and the amounts of
0.3 M NaCl and water taken in during the following 12 hr were
measured (Figure 7A). Among WT mice in a hydrated condition,(B) Changes in the signal intensity of the in situ hybridization for ET-3mRNA in the
that at 0 hr. *p < 0.05, two-tailed Student’s t test; ns, not significant; data are me
(C) Comparison of ET-3 levels secreted in SFO tissues of hydrated and 48 hr dehyd
incubated with a certain amount of control solution ([Na+]o = 145 mM), high-Na
+ s
high-K+ solution ([K+]o = 25mM) for 1 hr at 37
C. The ET-3 concentrations are show
each condition. **p < 0.01, two-tailed Student’s t test; data are mean ±SEM (n =
(D) Immunocytochemical detection of phosphorylated ERK1/2. The level of phosp
(E) In situ hybridization for detection of ET-1, ET-2, and ET-3 expression in the S
provided freely with food and water (Hydrated) or after 2 days without water (D
dehydration. Scale bars, 100 mm.
(F) Comparison of Ang II levels in the plasma and SFO tissues of mice under hydra
against that of the hydratedWTmouse. Somemice were treated with BQ788 (500
mean ±SEM (n = 6 for each). See also Figures S5 and S6.
Cthe preference ratio for the NaCl solution was slightly (not signif-
icantly) higher in the mice that received BQ788 (Figure 7B; WT,
Hydrated). After dehydration for 1 and 2 days, the preference
ratio for 0.3 M NaCl was markedly reduced in WT mice time
dependently, but the reduction was significantly attenuated in
the mice treated with BQ788 (Figure 7B; WT, Dehydrated). In
contrast, in Nax-KO mice, the preference ratio was not reduced
by dehydration (Figure 7B; KO, Hydrated and Dehydrated).
Moreover, it was not affected by the infusion by BQ788 in either
the hydrated or dehydrated group (Figure 7B; KO, Hydrated and
Dehydrated). These results suggest that ETBR activation in the
SFO enhances the sensitivity of the sodium sensor Nax, thereby
enhancing the salt-aversive behavior of the mice.
After dehydration, both WT and Nax-KO mice showed a noted
elevation in total fluid intake (Figure 7C) and a marked reduction
in urine volume (Figure 7D) in the same way. In addition, urine
[Na+] (Figure 7E) and serum [Na+] (Figure 7F) are slightly
increased in both genotypes. These results are consistent with
our previous reports (Watanabe et al., 2000; Hiyama et al.,
2004; Nagakura et al., 2010). Of note, the i.c.v. infusion of
BQ788 did not affect total fluid intake (Figure 7C), urine volume
(Figure 7D), [Na+] in urine (Figure 7E), or [Na+] in serum
(Figure 7F).
DISCUSSION
The concentration of Na+ in serum is strictly controlled at 135–
145mM, and when over 145mM results in a condition described
as hypernatremia (Gladden, 2004). This means that theminimum
threshold of the brain’s [Na+]o sensor for body-fluid homeostasis
is lower than 145 mM in vivo under normal conditions. In the
present study, we found that ET-3 is expressed in the SFOwhere
Nax is expressed and the sensitivity to [Na
+]o of Nax depends on
the concentration of ET-3; Nax begins to open in the physiolog-
ical [Na+]o range when [ET-3] is more than 0.3 nM. We also found
ET-3 expression to be commensurately enhanced in the SFO,
according to the dehydration of animals. This improvement of
the sensitivity of Nax to [Na
+]o by ET-3 probably plays an essen-
tial role in keeping Na+ concentrations in body fluids at normal
levels by inducing salt aversion.
ETBR is known to be expressed abundantly in the SFO as
compared to ETAR, though its physiological roles have not
been elucidated (Hindmarch et al., 2008). In the present study,
we revealed that ET-3 and ETBR are coexpressed in Nax-positive
glial cells in the SFO, along with ET-converting enzymes (Figures
1A–1E). Importantly, ET-3 appears to be secreted in the SFOSFO during dehydration. Signal intensities are shown as relative values against
an ±SEM (n = 8 for each).
ratedmice. Five SFO tissue samples dissected fromWTmice were collectively
olution ([Na+]o = 170 mM), high-osmolality solution (osmolality = 350 mOsm), or
n as relative values against that obtained from the SFO of hydratedmice under
6 for each).
horylated ERK1/2 in the SFOwas increased by dehydration. Scale bars, 50 mm.
FO of the WT and Nax-KO (KO) mouse brain. Brains were obtained from mice
ehydrated). The mRNA level of ET-3, but not ET-1 or -2, was increased by
ted or dehydrated (2 days) conditions. Ang II levels are shown as relative values
pmol/hr) during the dehydration. **p < 0.01, two-tailed Student’s t test; data are
ell Metabolism 17, 507–519, April 2, 2013 ª2013 Elsevier Inc. 515
AB C
D
Experimental strategy
Two-bottle test (without food)
food onlyfood and water
12 hr
Dehydrated (1day)
Computer
  Drop counter
<Two-bottle test>
W
at
er
W
at
er
0.3
 M
 
0.3
 M
 N
aC
l
N
aC
l
Hydrated
2 days
BQ788
2 days
BQ788
0
1
2
3
4
5
To
ta
l f
lu
id
 In
ta
ke
 fo
r 8
 h
 (m
l/3
0g
bw
)
Vehicle
BQ788
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
P
re
fe
re
nc
e 
fo
r 0
.3
 M
 N
aC
l Vehicle
BQ788
*
WT   KO   WT    WT    KO
Dehydrated
U
rin
e 
N
a 
(m
M
)
U
rin
e 
vo
lu
m
e 
(m
l/3
0g
bw
) VehicleBQ788
S
er
um
 N
a 
(m
M
)
E F
12 hr1 day
0
0.5
1.0
1.5
2.0
0
20
40
60
80
100
120
140
160
Vehicle
BQ788
180
0
20
40
60
80
100
120
140
160
180 Vehicle
BQ788
WT   KO   WT   KO
Hydrated Dehydrated
   (2 days)
5 days
5 days
Implantation of pump and cannula
*
2 days1 dayHydrated
WT   KO   WT    WT    KO
Dehydrated
2 days1 dayHydrated
WT   KO   WT   KO
Hydrated Dehydrated
(2 days)
WT   KO   WT   KO
Hydrated Dehydrated
   (2 days)
Dehydrated (2days) 2 days
BQ788
12 hr2 days5 days
1 day
Figure 7. ET Signaling Is Involved in the
Control of Salt-Intake Behavior in Mice
(A) Experimental design of the two-bottle test.
After recovery from the implantation of an osmotic
pump and cannula, the cannula was connected to
the tube from the pump. Subsequently, the mice
were housed with free access to water and food
(Hydrated) or deprived of water (Dehydrated) for
1 or 2 days. Then the mice underwent the two-
bottle test with 0.3 M NaCl and water. The mice
received an i.c.v. infusion of BQ788 or vehicle
during the period indicated with the bar under-
neath.
(B and C) Preference ratios for 0.3 M NaCl (B) and
total intake volume (C) in the two-bottle test during
12 hr. WT and Nax-KO (KO) mice received an i.c.v.
infusion of BQ788 or vehicle were compared. The
preference ratio was defined as the ratio of the
volume of 0.3M saline ingested to total fluid intake.
*p < 0.05, two-tailed Student’s t test; data are
mean ±SEM (n = 10 for each).
(D and E) Urine volumes (D) and [Na+] (E) of the
mice that received an i.c.v. infusion of BQ788 or
vehicle. Urine samples were collected for 24 hr
after the 2 day housing period indicated in (A). Data
are mean ±SEM (n = 10 for each).
(F) Serum [Na+] of the mice that received an i.c.v.
infusion of vehicle or BQ788 at the end of the 2 day
housing period indicated in (A). Data are
mean ±SEM (n = 10 for each).
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+](Figure 6C). Thus, ET-3 produced in the SFO likely activates
ETBR of Nax-positive glial cells in an autocrine or paracrine
fashion. As CVOs, including the SFO, lack a blood-brain barrier,
cells in the SFO are supposedly exposed to circulating
hormones, including ETs (Smith and Ferguson, 2010). However,
ET-3 levels in plasma and CSF remained low during the 1–2 days
of dehydration (ranged from 13 to 32 pM; see Supplemental
Information). Because ET-3 at 50 pM did not affect Nax gating
(Figure 3E), ET-3 in blood or CSF is unlikely to activate Nax chan-
nels in the SFO.
Importantly, 0.3 nM ET-3 is sufficient to partially activate Nax
channels under physiological conditions (Figures 1G, 1H, 2D,
and 5G). Here, it should be noted that a certain amount of ET-3
is detected also under hydrated normal conditions (Figures 1D
and 6A–6C). Based on the simple assumptions that ET-3 was
distributed evenly in the SFO tissue and completely eluted out
by incubation, the ET-3 level in the SFO after 48 hr dehydration516 Cell Metabolism 17, 507–519, April 2, 2013 ª2013 Elsevier Inc.was calculated to be 1 nM (see Supple-
mental Information). Although it is difficult
to estimate the local concentration of ET-
3 in the SFO, even higher concentrations
would be possible in vivo, because ET-3
is secreted into the intercellular space in
the SFO; the space is very small, because
processes of Nax-positive glial cells
tightly wrap the cell soma of neurons,
including GABAergic neurons (Watanabe
et al., 2006). These findings may suggest
that the basic level of ET-3 already shifts
the threshold of Nax lower than 145 mMin vivo and that this modulation is essential for keeping Na+ levels
in body fluids in the physiological range. Enhancement of the
sensitivity to [Na+]o by ETBR signaling probably brings about
significant activation of Nax even in slightly dehydrated animals
through induction of ET-3 expression in the SFO, and this may
help animals respond to dehydration steadily.
We demonstrated that Ang II does not induce Na+ influx in
Nax-positive cells (Figures 1G, 1H, and S1A). Ang II is a vasocon-
strictor peptide and promotes both water and salt intake (Paul
et al., 2006; Fitzsimons, 1998). Its receptors are also abundant
in the SFO, and the activation of Ang II receptors in the SFO
reportedly stimulates salt intake (Fitzsimons, 1998). This is the
opposite of Nax activation, which leads to the suppression of
salt intake (Noda, 2007). In addition, the data in Figures 6F and
S5 demonstrate that it is unlikely that there is direct interaction
between ETBR (or Nax) signaling and Ang II expression. More-
over, administration of BQ788 to hydrated animals did not affect
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ET-3 Activates Nax Channels at Physiological [Na
+]the stimulation of water or saline intake by i.c.v. injection of Ang II
(data not shown), indicating that the effects of Ang II under
hydrated conditions are independent of ETBR signaling, prob-
ably because ET-3 expression is not enhanced. However, there
remains the possibility that Nax signaling regulates downstream
of Ang II signaling in dehydrated animals (see below).
The fact that our baseline ingestion of salt is more than
adequate for maintaining fluid balance indicates that salt-
intake-promoting neurons are constitutively active at a certain
level under normal conditions. Salt appetite is enhanced in hypo-
natremia and hypovolemia through induction of Ang II. On the
other hand, inhibitory GABAergic neurons in the SFO, which
probably suppress salt intake, also appear to be active at
a certain level (they were firing at 4 Hz under normal [Na+]
conditions when analyzed ex vivo; Figure 5F; see also Shimizu
et al., 2007). When [Na+]o (or [ET-3]) was increased, the activity
of SFO GABAergic neurons was upregulated by Nax signaling
(8 Hz; Figure 5F; Shimizu et al., 2007); our data suggest that
this enhancement of the inhibition is enough to suppress salt
appetite (or to induce salt aversion). In Nax-KO mice, this inhibi-
tionmechanism is deficient, and it is conceivable that they do not
stop ingesting salt during dehydration. Thus, ET-3 is apparently
implicated in the sensing mechanism of [Na+] in body fluids by
Nax, whereas Ang II is involved in the upregulation of salt/
water-intake behaviors downstream. Salt intake would not be
enhanced when the SFO GABAergic neurons are highly acti-
vated by Nax signaling.
Neurons expressing Ang II receptors in the SFO appear to be
composed of several distinct species that are involved in the
stimulation of water intake, salt intake, vasopressin release,
and so on. Among them, neurons relevant to the salt-intake regu-
lation in the SFO presumably extend efferents to the bed nucleus
of the stria terminalis and the central nucleus of the amygdala
(Geerling and Loewy, 2008). As for the control mechanisms for
salt intake by Nax signaling, two possibilities are conceivable.
One possibility is that SFO GABAergic neurons themselves
project to these nuclei to control salt intake. Another is that
Nax signaling suppresses salt-intake-promoting projection
neurons in the SFO via GABAergic neurons. Further studies,
including the characterization of cell types and elucidation of
local circuits in the SFO, would be required to understand the
whole picture of brain mechanisms underlying salt homeostasis.
An important finding of the present study is that Nax is not only
[Na+]-sensitive but also [ET-3]-sensitive; that is, Nax has two
synergistic activation mechanisms. Our in vitro experiments
showed that Nax is fully open at a [Na
+]o of 140 mM when
[ET-3] is over 10 nM. Although it is not clear whether such condi-
tions actually occur in vivo, other Nax-positive cells might exist in
which Nax is activated solely by ET-3. Of note, Nax is also ex-
pressed in some regions other than the SFO, including myome-
trium of the pregnant uterus, peripheral nonmyelinating
Schwann cells, and pituicytes in the posterior pituitary (Wata-
nabe et al., 2000, 2002). However, the physiological roles of
Nax in these areas have not been elucidated. Nax is also ex-
pressed in alveolar type II cells in the lung, and the expression
level is markedly enhanced just before and after birth in infants
(Watanabe et al., 2002). We found that ET-3 expression is also
concomitantly induced in the lung at this developmental stage
(Figure S6).CThe finding that Nax activation by ETs leads to the release of
lactate from Nax-positive glial cells suggests a possible distinct
role for Nax. At sites of brain damage, increases in extracellular
lactate levels and activation of the uptake of lactate by neurons
are observed (Chen et al., 2000; Mendelowitsch et al., 2001). In
the CNS, we have observed that traumatic brain injury induces
expression of Nax in glial cells in damaged parts of the cortex
(our unpublished observation). Moreover, it has been reported
that ETBR expression is also upregulated in glial cells after trau-
matic brain injury (Sire´n et al., 2000) and ET-1 production
increases in the damaged area (Petrov et al., 2002). Therefore,
ETs may play an important role in the recovery from nerve injury
by inducing the release of lactate from Nax-positive cells.
In summary, this report demonstrates the existence of
a dynamic mechanism—a change in the threshold of the [Na+]
sensor for body fluids caused by the local expression of a vaso-
relaxation hormone, ET-3—in the SFO. This mechanism prob-
ably underlies the sensing of Na+ concentrations in body fluids
in vivo. ETBR signaling subserves activation of Nax channels
and leads to the enhancement of glucose metabolism and
lactate release in Nax-bearing glial cells. This supply of lactate
from glial cells eventually results in the activation of GABAergic
neurons in the SFO. The activation of inhibitory neurons in the
SFO is supposedly responsible for the negative control of salt
appetite. Our findings thus provide insights into not only the
gating mechanism of Nax channels but also the physiological
role of ET-3 in the SFO for salt homeostasis through neural
control by glial cells.
EXPERIMENTAL PROCEDURES
For a detailed description of the procedures and other methods used, see
Supplemental Information.
Experimental Animals
All experimental protocols with animals were reviewed and approved by The
Institutional Animal Care and Use Committee of National Institutes of Natural
Sciences, Japan (approval numbers 09A183, 10A236, 11A128, and 12A051).
Male WT (C57BL/6J, CLEA Japan), homozygous Nax-KO, heterozygous
GAD67-GFP (Dneo) knockin (GAD-GFP), or GAD-GFP on the Nax-KO genetic
background (GAD-GFP/Nax-KO) mice (Watanabe et al., 2006) at 8–12 weeks
of age were used.
Intracellular Na+ Imaging
Na+ imaging was performed as described previously (Hiyama et al., 2010).
Background fluorescence ratios of host cells without Nax expression [Tet-off
()] were subtracted from the respective values. For the curve fitting in Fig-
ure 3E, see Supplemental Experimental Procedures.
Patch-Clamp Experiments with Dissociated SFO Cells
For long-term recordings of whole-cell currents with better retention of intra-
cellular constituents, the perforated patch method using b-escin was em-
ployed (Fan and Palade, 1998). The extracellular solution contained (in mM):
5 KCl, 2.5 CaCl2, 1 MgCl2, 20 HEPES, 10 NaOH, and appropriate amounts
of NaCl (pH 7.4). Osmolality was adjusted to 350 mOsm with mannitol. The
pipette solution contained (in mM): 120 Cs methanesulfonate, 20 TEA-Cl,
2 MgCl2, 2 Na2ATP, 1 EGTA, 10 HEPES, and 2 NaOH (pH 7.3). b-escin (30–
50 mM) was added to the solution on the day of experiments, and osmolality
was adjusted to 340mOsmwith mannitol. For the detection of Na+-dependent
currents, extracellular solutions were changed by the fast application method
using a double-barreled application pipette (Johnson and Ascher, 1987). The
pipette was operated by a piezoelectric device (PZ-150M, Burleigh
Instruments).ell Metabolism 17, 507–519, April 2, 2013 ª2013 Elsevier Inc. 517
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+]Electrophysiology with SFO Slices
The electrophysiological experiments with the GAD-GFP and GAD-GFP/Nax-
KO mice were performed as reported elsewhere (Shimizu et al., 2007).
Estimation of ET-3 Levels in the SFO
To compare ET-3 secretion in various solutions, SFO tissues (n = 5) dissected
fromWTmice were collectively incubated with 100 ml modified Ringer solution
(control solution; [Na+]o = 145 mM), the solution with additional NaCl (high-Na
+
solution; [Na+]o = 170 mM), the solution with additional mannitol (high-osmo-
lality solution; osmolality = 350 mOsm), or the solution with additional KCl
(high-K+ solution; [K+]o = 25 mM) for 1 hr at 37
C. Measurements were per-
formed according to the manufacturer’s instructions for the ET-3 radioimmu-
noassay kit (Bachem).
Intracerebroventricular Infusion
Mice were implanted with i.c.v. minipumps for chronic central infusion of the
ETBR-specific antagonist BQ788. Animals were allowed 5 days to recuperate.
Subsequently, the cannula was connected to the pump with a polyethylene
catheter to allow i.c.v. infusion of the drug. Osmotic minipumps (1002, alzet),
which continuously deliver dissolved substances at a rate of 0.25 ml/hr, were
filled with 2 mM BQ788 or vehicle (modified Ringer solution).
Two-Bottle Test
Two days after the start of the i.c.v. infusion, the ingested volume of distilled
water or 0.3 M NaCl solution was measured for 12 hr. Preference in the two-
bottle test was evaluated as a ratio of the volume of saline ingested to the total
intake.
Statistical Analysis
Data were tested for statistical significance with Kyplot software (Kyens).
p < 0.05 was considered statistically significant. Data are mean ±SEM.SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, Supplemental Results, Supple-
mental Discussion, and Supplemental Experimental Procedures and can be
found with this article online at http://dx.doi.org/10.1016/j.cmet.2013.02.018.
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